SINGLE ANTIPLATELET THERAPY AFTER DRUG-COATED BALLOON PCI IN HIGH-BLEEDING RISK PATIENTS AND STABLE CORONARY ARTERY DISEASE OR ACUTE CORONARY SYNDROMES | Publicación